What Is A Birth Defect?
Majority of birth defects take place during the crucial stages of early fetal development, commonly known as the first trimester or 12 weeks. A birth defect has the potential to affect how the baby’s body looks and or works. Some birth abnormalities like cleft lip and cleft palate are considered structural problems that are easy to detect. However, for heart defects or congenital abnormalities special tests need to be done. Although birth abnormalities are not uncommon (one in every 33 babies is born with one in the United States) the causes of them can range from genetic mutations all the way to drugs that the mother took while pregnant. This is where Zofran comes into play as an agent for birth abnormalities.
A large volume of accounts have been documented about the heightened risk of a baby being born with defects like cleft palate and congenital heart defects if Zofran was consumed by an expectant mom in the first three months of pregnancy. Several medical studies have been conducted that have decisively correlated Zofran to these types of birth irregularities. Those affected by the use of Zofran have been filing lawsuits against the creators of the drug (GlaxoSmithKline) for neglecting to clearly warn of the possible dangers of taking Zofran. Expectant mothers used Zofran under the direction of their doctor as a ‘safe’ drug to use for severe morning sickness. Unfortunately, this was not the case as their babies ended up being born with Zofran related birth defects.
Nebraska Stats About Infant Birth Defects
As of the recently recorded census data, Nebraska’s residents totaled 1,881,503. In terms of the most densely inhabited cities, the cities and numbers are as follows:
- Omaha- 408,958 population
- Lincoln- 258,379 population
- Bellevue- 50,137 population
- Grand Island- 48,520 population
- Kearney- 30,787 population
It is estimated that for every 33 newborns in America, one will have some type of birth abnormality. From the time that Zofran became extensively available in 1991, it skyrocketed to being a drug with the most written scripts in all of America. By 2005 the drug boasted 99% market share. Utilizing this data our Zofran attorneys have readied estimations of probable cases of births that had a negative Zofran influenced birth defect, while also incorporating the averaged risk ratios classified in the various epidemiological studies that were undertaken. Our estimations bring us to 982 Nebraska newborns with Zofran related abnormalities where Zofran was taken in the first 12 weeks of fetal development.
What Are The Nebraska Cleft Palate & Congenital Heart Defect Estimates In Nebraska?
As already cited in this article, Zofran was made accessible to the United States’ public in 1991. The drug had three patents that propelled it to gain market supremacy all the way through to 2006. As of that time generic versions were also accessible. We have calculated the estimations of cleft palate and congenital heart defects from the afore estimated 982 summation of the overall birth defects in Nebraska. Our estimations are that there were 176 birth deformities that were some type of cleft palate, and 806 births that had congenital heart defects or hole in the heart. We further calculated the Nebraska five largest cities estimations of cleft palate and hole in the heart defects:
- Omaha- 242 infant birth irregularities (nearly: 39 cleft palate and 203 congenital heart defects)
- Lincoln- 170 infant birth irregularities (nearly: 23 cleft palate and 147 congenital heart defects)
- Bellevue- 74 infant birth irregularities (nearly: 5 cleft palate and 69 congenital heart defects)
- Grand Island- 73 infant birth irregularities (nearly: 5 cleft palate and 68 congenital heart defects)
- Kearney- 64 infant birth irregularities (nearly: 2 cleft palate and 62 congenital heart defects)
What Are The Documented Zofran Adverse Effects?
In the most currently filed cases, litigants have gone on record stating that Zofran was the agent that resulted in their child being born with severe birth deformities. Also, in all cases the mother was prescribed Zofran for severe morning sickness in the early stages of pregnancy. The complainants also base their accusations on the different types of clinical studies performed in medical communities all over the world. Some of the documented birth defects that have been recorded in lawsuits are as follows:
- Atrial Septal Defect
- Ventricular Septal Defect
- Cardiac Septum Defect
- Renal Deformations
- Cleft Palate
- Facial Dysmorphia
- Webbed Toes
- Low set ears
- Bicuspid aortic stenosis
- Club foot
Nebraska Parents Visiting ZofranLegal.com For Zofran Lawsuits Information
The law firms of Monheit Law, Janet Jenner & Suggs, Grant Eisenhofer, Markhoff & Mittman, and Banville Law, are the proprietors of ZofranLegal.com. This website was designed with the intention of bringing relevant and timely news about the Zofran suit. Even though our advocates are not certified to practice law in the state of Nebraska, we are certified to practice law in Delaware. We also have offices in Delaware where we can file your case from. We consider Delaware an important state as it is where the makers of Zofran, GSK have their HQ. This means we can present your case before the court of law in Delaware state.
Numerous families from Nebraska have made contact with us either through contact forms or by calling us. The families contacting us are of the understanding that their child’s birth irregularity was caused by Zofran when the mother took the drug for morning sickness relief in the first 12 weeks of her pregnancy. On assessment of your case we offer various ways to file your lawsuit. Your suit can be filed in Delaware State where we have offices and can represent you, or we may advise another venue for you to file. Nebraska legal counsel can also be recommended using counsel from our trusted legal network. If you would like to meet our Zofran advocates visit this page here. Our advocates are also here to speak with you at any time of the day so please call us.